MedPath

The efficacy of intranasal administration of Naloxone by paramedics for the successful treatment of suspected heroin overdose in the prehospital setting.

Phase 4
Completed
Conditions
Opiate Overdose
Mental Health - Addiction
Registration Number
ACTRN12606000322538
Lead Sponsor
Department of Human Services, Australian Government.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
200
Inclusion Criteria

All suspected opiate overdose victims in the prehospital setting to be treated by paramedics with naloxone will be included in this study, regardless of age or gender .Client unrousable i.e. GCS less than 13.No major facial trauma/blocked nasal passages/epistaxis.

Exclusion Criteria

Client rousable i.e. GCS Greater than 12.Major facial trauma/blocked nasal passages/epistaxis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Requirement for subsequent treatment with Naloxone[At 10 minutes from randomisation treatment.]
Secondary Outcome Measures
NameTimeMethod
Time to adequate and effective spontaneous respirations.[10 minutes.];Time to adequate consciousness.[10 minutes]
© Copyright 2025. All Rights Reserved by MedPath